Avanos Medical (AVNS)

Executive Summary

Avanos Medical is a Belgium-based medical technology company focused on developing non-opioid pain management and enteral feeding solutions to improve patient recovery and quality of life. The company's core product portfolio includes the ON-Q elastomeric and electronic pain pumps, the COOLIEF cooled radiofrequency ablation system for chronic pain, and a comprehensive suite of enteral feeding tubes, pumps, and accessories. By providing alternatives to opioids and supporting nutritional needs, Avanos addresses critical healthcare challenges in postoperative pain, chronic pain, and malnutrition. The company competes in the large and growing pain management and enteral nutrition markets, with a strong emphasis on innovation and clinical evidence. In recent years, Avanos has focused on expanding its COOLIEF platform into new therapeutic areas, such as knee osteoarthritis and sacroiliac joint pain, while also optimizing its enteral feeding business for growth. The company benefits from favorable demographics, including an aging population and increasing number of surgeries, as well as regulatory tailwinds promoting non-opioid pain management. Despite competitive pressures, Avanos has maintained a solid market position through differentiated technology and recurring revenue from consumables. Looking ahead, the company is expected to drive growth through new product launches, geographic expansion, and strategic partnerships, all while managing supply chain and healthcare budget headwinds.

Upcoming Catalysts (preview)

• Q3 2026FDA clearance of next-generation COOLIEF for knee osteoarthritis80% success
• Q1 2027Positive pivotal trial results for enteral feeding tube with reduced dislodgement70% success
• TBDStrategic partnership or acquisition in pain management space50% success